(Q44445114)

English

The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma

scientific article published on 10 February 2013

In more languages
default for all languages
No label defined

No description defined

Statements

The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma (English)
0 references
Ching-Wei David Tzeng
Matthew Harold Katz
Christopher H Crane
Gauri R Varadhachary
James L Abbruzzese

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit